검색어 : 통합검색[Gates Robert Michael]
총 149건 중 149건 출력
, 15/15 페이지
-
141
- Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)
- Barbagelata, Alejandro; Califf, Robert M; Sgarbossa, Elena B; Goodman, Shaun G; Knight, David; Mark, Daniel B; Granger, Christopher B; Agranatti, Daniel A; Mautner, Branco; Ohman, E.Magnus; Suá rez, Luis D; Armstrong, Paul W; Gates, Kathy; Wagner, Galen S; ; (The American journal of cardiology, v.86, 2000, pp.24-29)
-
142
- The TLR4 antagonist Eritoran protects mice from lethal influenza infection
- Shirey, Kari Ann; Lai, Wendy; Scott, Alison J.; Lipsky, Michael; Mistry, Pragnesh; Pletneva, Lioubov M.; Karp, Christopher L.; McAlees, Jaclyn; Gioannini, Theresa L.; Weiss, Jerrold; Chen, Wilbur H.; Ernst, Robert K.; Rossignol, Daniel P.; Gusovsky, Fabian; Blanco, Jorge C. G.; Vogel, Stefanie N.; Department of Microbiology and Immunology, University of Maryland, Baltimore, Baltimore, Maryland 21201, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, Baltimore, Maryland 21201, USA; Department of Microbial Pathogenesis, University of Maryland, Baltimore, Baltimore, Maryland 21201, USA; Department of Pathology, University of Maryland, Baltimore, Baltimore, Maryland 21201, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, Baltimore, Maryland 21201, USA; Sigmovir Biosystems, Inc., Rockville, Maryland 20850, USA; 1] Division of Molecular Immunology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, Ohio 45229, USA [2] The Bill & Melinda Gates Foundation, Seattle, Washington 98109, USA (C.L.K.); Taisho Pharmaceutical R&D, Inc., Morristown, New Jersey 07960, USA (D.P.R.).; Division of Molecular Immunology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, Ohio 45229, USA; 1] The Inf; (Nature, v.497, 2013, pp.498-502)
-
143
- Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial
- Meduri, Christopher U.; Kereiakes, Dean J.; Rajagopal, Vivek; Makkar, Raj R.; O'Hair, Daniel; Linke, Axel; Waksman, Ron; Babliaros, Vasilis; Stoler, Robert C.; Mishkel, Gregory J.; Rizik, David G.; Iyer, Vijay S.; Schindler, John; Allocco, Dominic J.; Meredith, Ian T.; Feldman, Ted E.; Reardon, Michael J.; Piedmont Heart Institute Atlanta GA; The Christ Hospital Heart and Vascular Center The Lindner Research Center Cincinnati OH; Piedmont Heart Institute Atlanta GA; Cedars-Sinai Heart Institute Los Angeles CA; Aurora St. Luke's Medical Center Milwaukee WI; Dresden University Hospital, Heart Center Dresden Germany; Washington Hospital Center Washington DC; Emory University Hospital Emory University Atlanta GA; Baylor Heart & Vascular Hospital Dallas TX; St. John's Hospital Springfield IL; HonorHealth and the Scottsdale‐ Lincoln Health Network Scottsdale AZ; University at Buffalo/Gates Vascular Institute Buffalo NY; University of Pittsburgh Medical Center Pittsburgh PA; Boston Scientific Corp Marlborough MA; Boston Scientific Corp Marlborough MA; Edwards Lifesciences Irvine California; Houston Methodist DeBakey Heart and Vascular Center Houston TX; (Journal of the American Heart Association : cardiovascular and cerebrovascular disease, v.8, 2019, pp.e012594)
-
144
- Minimizing SARS-CoV-2 exposure when performing surgical interventions during the COVID-19 pandemic
- Pandey, Aditya S; Ringer, Andrew J; Rai, Ansaar T; Kan, Peter; Jabbour, Pascal; Siddiqui, Adnan H; Levy, Elad I; Snyder, Kenneth V; Riina, Howard; Tanweer, Omar; Levitt, Michael R; Kim, Louis J; Veznedaroglu, Erol; Binning, Mandy J; Arthur, Adam S; Mocco, J; Schirmer, Clemens; Thompson, Byron Gregory; Langer, David; Bain, Mark; Bendock, Bernard; Boulos, Alan S.; Crowley, Webster; Fessler, Richard; Grande, Andrew; Guterman, Lee; Hanel, Ricardo; Daniel Hoit; , L; Hopkins, Nelson; Howington, Jay; James, Robert; Jankowitz, Brian; Khalessi, Alex A; Lanzino, Giuseppe; Lopes, Demetrius; Mack, William; Mericle, Robert; Ogilvy, Chris; Replogle, Robert; Rodriguez, Rafael; Saugaveau, Eric; Spiotta, Alex; Sultan, Ali; Tawk, Rabih; Thomas, Ajith; Turner, Raymond; Welch, Babu; White, Jonathan; Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA; Neurosurgery, Mayfield Clinic, University of Cincinnati, Cincinnati, Ohio, USA; Interventional Neuroradiology, West Virginia University Hospital, Morgantown, West Virginia, USA; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA; Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA; Neurosurgery, University at Buffalo, Buffalo, New York, USA; Neurosurgery and Radiology and Canon Stroke and Vascular Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA; Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo, New York, USA; Department of Neurosurgery, New York University - Langone Medical Center, New York, New York, USA; Department of Neurosurgery, New York University - Langone Medical Center, New York, New York, USA; Neurological Surgery, Radiology and Mechanical Engineering,; (Journal of neurointerventional surgery, v.12, 2020, pp.643-647)
-
145
- Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis : The REPRISE III Randomized Clinical Trial
- Feldman, Ted E.; Reardon, Michael J.; Rajagopal, Vivek; Makkar, Raj R.; Bajwa, Tanvir K.; Kleiman, Neal S.; Linke, Axel; Kereiakes, Dean J.; Waksman, Ron; Thourani, Vinod H.; Stoler, Robert C.; Mishkel, Gregory J.; Rizik, David G.; Iyer, Vijay S.; Gleason, Thomas G.; Tché tché , Didier; Rovin, Joshua D.; Buchbinder, Maurice; Meredith, Ian T.; Gö tberg, Matthias; Bjursten, Henrik; Meduri, Christopher; Salinger, Michael H.; Allocco, Dominic J.; Dawkins, Keith D.; Evanston Hospital Cardiology Division, Northshore University Health System, Evanston, Illinois; Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas; Piedmont Heart Institute, Atlanta, Georgia; Cedars-Sinai Heart Institute, Los Angeles, California; Aurora St Luke’s Medical Center, Milwaukee, Wisconsin; Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas; University of Leipzig, Heart Center and Leipzig Heart Institute, Leipzig, Germany; Christ Hospital Heart and Vascular Center/Lindner Research Center, Cincinnati, Ohio; Washington Hospital Center, Washington, DC; Washington Hospital Center, Washington, DC; Baylor Heart and Vascular Hospital, Dallas, Texas; St John’s Hospital, Springfield, Illinois; HonorHealth and the Scottsdale-Lincoln Health Network, Scottsdale, Arizona; University at Buffalo/Gates Vascular Institute, Buffalo, New York; University of Pittsburgh Medical Cent; (JAMA : the journal of the American Medical Association, v.319, 2018, pp.27)
-
146
- Meeting report: 34th international conference on antiviral research
- Brancale, Andrea; Carter, Kara; Delang, Leen; Deval, Jerome; Durantel, David; Gentry, Brian G; Jordan, Robert; Julander, Justin G.; Lo, Michael K.; Pé rez-Pé rez, Maria-Jesú s; Schang, Luis M.; Seley-Radtke, Katherine L.; Shi, Pei-Yong; Vasudevan, Subhash G.; Whitley, Richard J.; Spengler, Jessica R.; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK; Evotec SE, Hamburg, Germany; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium; Aligos Therapeutics, Inc., San Francisco, CA, USA; CIRI - Centre International de Recherche en Infectiologie , Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Lyon, 69007, France; Department of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences, Drake University , Des Moines, IA, USA; Bill and Melinda Gates Foundation , Seattle, WA, USA; Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, USA; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention , Atlanta, GA, USA; Instituto de; (Antiviral chemistry & chemotherapy, v.30, 2022, pp.20402066221130853)
-
147
- Characteristics and birth outcomes of pregnant adolescents compared to older women: An analysis of individual level data from 140,000 mothers from 20 RCTs
- Akseer, Nadia; Keats, Emily Catherine; Thurairajah, Pravheen; Cousens, Simon; Bé tran, Ana Pilar; Oaks, Brietta M.; Osrin, David; Piwoz, Ellen; Gomo, Exnevia; Ahmed, Faruk; Friis, Henrik; Belizá n, José ; Dewey, Kathryn; West, Keith; Huybregts, Lieven; Zeng, Lingxia; Dibley, Michael J.; Zagre, Noel; Christian, Parul; Kolsteren, Patrick Wilfried; Kaestel, Pernille; Black, Robert E.; El Arifeen, Shams; Ashorn, Ulla; Fawzi, Wafaie; Bhutta, Zulfiqar Ahmed; Centre for Global Child Health, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; Centre for Global Child Health, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; Centre for Global Child Health, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; London School of Hygiene and Tropical Medicine, London, United Kingdom; World Health Organization, Switzerland; University of Rhode Island, United States; Institute for Global Health, University College London, United Kingdom; The Bill and Melinda Gates Foundation, United States; University of Zimbabwe, Zimbabwe; Griffith University, Australia; University of Copenhagen, Denmark; UNC Chapel Hill, United States; University of California, Davis, United States; Johns Hopkins Bloomberg School of Public Health, United States; International Food Policy Research Institute, United States; School of Public Health, Xi'an Jiaotong University Health Science Centre, China; The University of Sydney, Australia; UNICEF Regi; (Eclinicalmedicine, v.45, 2022, pp.101309)
-
148
- Building a tuberculosis-free world: The <i>Lancet</i> Commission on tuberculosis
- Reid, Michael J A; Arinaminpathy, Nimalan; Bloom, Amy; Bloom, Barry R; Boehme, Catharina; Chaisson, Richard; Chin, Daniel P; Churchyard, Gavin; Cox, Helen; Ditiu, Lucica; Dybul, Mark; Farrar, Jeremy; Fauci, Anthony S; Fekadu, Endalkachew; Fujiwara, Paula I; Hallett, Timothy B; Hanson, Christy L; Harrington, Mark; Herbert, Nick; Hopewell, Philip C; Ikeda, Chieko; Jamison, Dean T; Khan, Aamir J; Koek, Irene; Krishnan, Nalini; Motsoaledi, Aaron; Pai, Madhukar; Raviglione, Mario C; Sharman, Almaz; Small, Peter M; Swaminathan, Soumya; Temesgen, Zelalem; Vassall, Anna; Venkatesan, Nandita; van Weezenbeek, Kitty; Yamey, Gavin; Agins, Bruce D; Alexandru, Sofia; Andrews, Jason R; Beyeler, Naomi; Bivol, Stela; Brigden, Grania; Cattamanchi, Adithya; Cazabon, Danielle; Crudu, Valeriu; Daftary, Amrita; Dewan, Puneet; Doepel, Laurie K; Eisinger, Robert W; Fan, Victoria; Fewer, Sara; Furin, Jennifer; Goldhaber-Fiebert, Jeremy D; Gomez, Gabriela B; Department of Medicine, University of California San Francisco; School of Public Health, Imperial College London; Tuberculosis Division, United States Agency for International Development; Department of Global Health and Population, Harvard University; Foundation for Innovative New Diagnostics; Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine; Bill & Melinda Gates Foundation; The Aurum Institute; Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town; Stop TB Partnership; Department of Medicine, Centre for Global Health and Quality, Georgetown University; The Wellcome Trust; (The Lancet, v.393, 2019, pp.1331-1384)
-
149
- 2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)
- Tounekti, Omar; Prior, Sandra; Wassmer, Sarah; Xu, Joshua; Wong, Adrian; Fang, Xiaodong; Sonderegger, Ivo; Smeraglia, John; Huleatt, James; Loo, LiNa; Beaver, Christopher; DelCarpini, Jason; Dessy, Francis; Diebold, Sandra; Fiscella, Michele; Garofolo, Fabio; Grimaldi, Christine; Gupta, Swati; Hou, Victor; Irwin, Chad; Jani, Dewal; Joseph, Julie; Kalina, Warren; Kar, Sumit; Kavita, Uma; Lu, Yanmei; Marshall, Jean-Claude; Mayer, Christian; Mora, Johanna; Nolan, Katrina; Peng, Kun; Riccitelli, Nathan; Scully, Ingrid; Seitzer, Jessica; Stern, Mark; Wadhwa, Meenu; Xu, Yuanxin; Verthelyi, Daniela; Sumner, Giane; Clements-Egan, Adrienne; Chen, Cecil; Gorovits, Boris; Torri, Albert; Baltrukonis, Daniel; Gunn, George; Ishii-Watabe, Akiko; Kramer, Daniel; Kubiak, Robert J.; Mullins, Garrett; Pan, Luying; Partridge, Michael A; Poetzl, Johann; Rasamoelisolo, Michele; Sirtori, Federico Riccardi; Richards, Susan; Saad, Ola M.; Shao, Weiping; ; Health Canada, Ottawa; UK MHRA; Health Canada, Ottawa; US FDA, Jefferson; Health Canada, Ottawa; AskBio, Research Triangle Park; Takeda, Opfikon; AstraZeneca, Cambridge; Gates Medical Research Institute; Vertex, Boston; Takeda, Cambridge; Moderna, Mystic; GlaxoSmithKline, Rixensart; UK MHRA; REGENXBIO, Rockville; BRI Frontage, Vancouver; Regeneron, Tarrytown; AbbVie, Irvine; Moderna, Mystic; Health Canada, Ottawa; Takeda, San Diego; Health Canada, Ottawa; Pfizer, Pearl River; WRIB, Toronto, ON; Spark, Philadelphia; Sangamo, South San Francisco; Moderna, Mystic; Austria AGES, Vienna; Bristol Myers Squibb, Lawrenceville; Merck, West Point, PA, USA; Genentech, South San Francisco; Navigate, a Novartis Subsidiary, San Diego; Pfizer, Pearl River; Intellia, Cambridge; Bristol Myers Squibb, Lawrenceville; UK MHRA; Intellia, Cambridge; US FDA, Silver Spring; Regeneron, Tarrytown; Larimar, Bala Cynwyd; AstraZeneca, South San Francisco; Regeneron, Tarryto; (Bioanalysis, v.17, 2025, pp.105-149)
QUICK MENU
